CureVac AG has stressed that it knew nothing of any offers from the White House for its coronavirus vaccine candidate after a fevered few days for the German biotech firm that have seen two changes of CEO, as it found itself at the center of a media storm in the midst of a pandemic.
“There is no takeover offer from the White House or governmental authorities neither to the technology or to CureVac as...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
